NCT06514547View on ClinicalTrials.gov

Vaccine Immunity and Inflammation in the Aging Person Living With HIV

PHASE4RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

July 8, 2024

Primary Completion Date

September 15, 2028

Study Completion Date

June 30, 2029

Conditions
HIV InfectionsAge
Interventions
BIOLOGICAL

Conjugate Pneumococcal Vaccine 20 (PCV20)

Vaccine

Trial Locations (1)

55415

RECRUITING

Hennepin Healthcare System, Minneapolis

Sponsors
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Hennepin Healthcare Research Institute

OTHER